SCHEMBL7248442

SCHEMBL7248442

CCC(=O)Oc1ccc(-c2cccc(Cl)c2)cc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.51
MAPT P10636 2/20 0.45
PPARG P37231 2/20 0.43
PPARA Q07869 1/20 0.43
CTSA P10619 1/20 0.43
ACHE P22303 1/20 0.43
SLC6A9 P48067 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
FFAR1 O14842 2/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
ACLY P53396 1/20 0.41
MMEL1 Q495T6 1/20 0.41
DCLRE1B Q9H816 1/20 0.41
PPARD Q03181 1/20 0.41
ALOX5 P09917 1/20 0.41
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3834865 0.84 CYP1A2 (0.56) ESR2MAPTACHECYP1A2CYP2C9
SCHEMBL9799902 0.84 CYP1A2 (0.56) ESR2MAPTACHECYP1A2CYP2C9
SCHEMBL27934248 0.82 CYP1A2 (0.55) ESR2MAPTACHECYP1A2CYP2C9
SCHEMBL812909 0.80 ESR2 (0.48) ESR2MAPTPPARGPPARACTSA
SCHEMBL27542876 0.74 CYP1A2 (0.57) ESR2MAPTCYP1A2CYP2C9HIF1A
SCHEMBL811810 0.74 ESR2 (0.50) ESR2MAPTCTSAFFAR1MMEL1
SCHEMBL7537504 0.74 L3MBTL1 (0.59) MAPTACHEHIF1AMRGPRX4ALOX15
SCHEMBL15546827 0.74 ALOX15 (0.58) MAPTACHECYP1A2CYP2C9HIF1A
SCHEMBL1678635 0.72 L3MBTL1 (0.55) MAPTCYP1A2CYP2C9ALOX15TSHR
SCHEMBL11332752 0.72 ACHE (0.59) ACHEHIF1AALOX15KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555663-B1 Pharmaceuticals which are activated intracellularly by reaction with cellular electron carriers or free radicals to cause release of a free and active drug molecule MILLS RANDELL LEE (US) 2003-04-29 US disclosed
US-5773592-A COMPRISES A CHEMILUMINESCENT MOIETY, A PHOTOCHROMIC MOIETY AND A BIOLOGICALLY ACTIVE AGENT CAPABLE OF BEING RELEASED MILLS RANDELL LEE (US) 1998-06-30 US disclosed
EP-0414730-A4 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS 1993-06-16 EP disclosed
EP-0414730-A1 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS Mills, Randell L. (US) 1991-03-06 EP disclosed
WO-1989009833-A1 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS MILLS RANDELL L (US) 1989-10-19 WO disclosed